Related Experiment Videos
Ectopic production of calciotropic peptides
1Department of Medicine, University of Texas Health Science Center, San Antonio.
Endocrinology and Metabolism Clinics of North America
|September 1, 1991
Summary
Cancer can disrupt bone health and calcium balance, leading to paraneoplastic syndromes. Hypercalcemia of malignancy is the most common, but hypocalcemia, hypophosphatemia, and osteomalacia also occur.
Area of Science:
- Oncology
- Endocrinology
- Bone Metabolism
Background:
- Tumors often impact bone cell function and calcium homeostasis.
- Paraneoplastic syndromes are a frequent complication in cancer patients.
- These syndromes can significantly affect mineral balance and skeletal integrity.
Purpose of the Study:
- To summarize the key paraneoplastic syndromes related to cancer and bone metabolism.
- To highlight the prevalence and types of calcium and phosphate dysregulation in malignancy.
Main Methods:
- Literature review of paraneoplastic syndromes in oncology.
- Analysis of the relationship between tumors, bone cells, and calcium homeostasis.
Main Results:
- Hypercalcemia of malignancy is the most common paraneoplastic syndrome.
- Other significant syndromes include hypocalcemia, hypophosphatemia, and osteomalacia.
- These conditions underscore the systemic effects of cancer on mineral metabolism.
Conclusions:
- Cancer-associated alterations in bone cell function and calcium homeostasis are clinically significant.
- Recognizing these paraneoplastic syndromes is crucial for patient management.
- Further research into the mechanisms underlying these syndromes is warranted.